Fuertes, Baby Boy .

HRN: 22-13-86  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/27/2022
AMPICILLIN 250MG (VIAL)
10/27/2022
11/02/2022
IVT
170mg
Q12
Maternal Factor: (+) RAgT; Thinly MSAF
Waiting Final Action 
10/27/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
10/27/2022
11/02/2022
IVT
50mg
OD
Maternal Factor: (+) RAgT; Thinly MSAF
Waiting Final Action 
10/30/2022
AMPICILLIN 250MG (VIAL)
10/30/2022
11/03/2022
IV
170mg
Q12
Maternal Factors: (+) RAgT; Thinly MSAF
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: